Schramm C - Search Results

1

Treating hepatitis D with bulevirtide - Real-world experience from 114 patients.

Dietz-Fricke C, Tacke F, Zöllner C, Demir M, Schmidt HH, Schramm C, Willuweit K, Lange CM, Weber S, Denk G, Berg CP, Grottenthaler JM, Merle U, Olkus A, Zeuzem S, Sprinzl K, Berg T, van Bömmel F, Wiegand J, Herta T, Seufferlein T, Zizer E, Dikopoulos N, Thimme R, Neumann-Haefelin C, Galle PR, Sprinzl M, Lohse AW, Schulze Zur Wiesch J, Kempski J, Geier A, Reiter FP, Schlevogt B, Gödiker J, Hofmann WP, Buggisch P, Kahlhöfer J, Port K, Maasoumy B, Cornberg M, Wedemeyer H, Deterding K. Dietz-Fricke C, et al. Among authors: schramm c. JHEP Rep. 2023 Mar 15;5(4):100686. doi: 10.1016/j.jhepr.2023.100686. eCollection 2023 Apr. JHEP Rep. 2023. PMID: 37025462 Free PMC article.

2

Thiamine for the treatment of nucleoside analogue-induced severe lactic acidosis.

Schramm C, Wanitschke R, Galle PR. Schramm C, et al. Eur J Anaesthesiol. 1999 Oct;16(10):733-5. doi: 10.1046/j.1365-2346.1999.00586.x. Eur J Anaesthesiol. 1999. PMID: 10583359

3

Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series.

Schramm C, Schirmacher P, Helmreich-Becker I, Gerken G, zum Büschenfelde KH, Lohse AW. Schramm C, et al. Ann Intern Med. 1999 Dec 21;131(12):943-6. doi: 10.7326/0003-4819-131-12-199912210-00006. Ann Intern Med. 1999. PMID: 10610645

4

Rapid development of Epstein-Barr virus-associated Hodgkin's disease after cessation of foscarnet therapy in an HIV-infected patient.

Schramm C, Schlaak JF, Galle PR. Schramm C, et al. Int J STD AIDS. 2000 Sep;11(9):609-10. doi: 10.1258/0956462001916489. Int J STD AIDS. 2000. PMID: 10997507

5

Autoimmune hepatitis in the elderly.

Schramm C, Kanzler S, zum Büschenfelde KH, Galle PR, Lohse AW. Schramm C, et al. Am J Gastroenterol. 2001 May;96(5):1587-91. doi: 10.1111/j.1572-0241.2001.03782.x. Am J Gastroenterol. 2001. PMID: 11374704

6

Impairment of TGF-beta signaling in T cells increases susceptibility to experimental autoimmune hepatitis in mice.

Schramm C, Protschka M, Köhler HH, Podlech J, Reddehase MJ, Schirmacher P, Galle PR, Lohse AW, Blessing M. Schramm C, et al. Am J Physiol Gastrointest Liver Physiol. 2003 Mar;284(3):G525-35. doi: 10.1152/ajpgi.00286.2002. Epub 2002 Dec 4. Am J Physiol Gastrointest Liver Physiol. 2003. PMID: 12466145 Free article.

7

TGF-beta regulates airway responses via T cells.

Schramm C, Herz U, Podlech J, Protschka M, Finotto S, Reddehase MJ, Köhler H, Galle PR, Lohse AW, Blessing M. Schramm C, et al. J Immunol. 2003 Feb 1;170(3):1313-9. doi: 10.4049/jimmunol.170.3.1313. J Immunol. 2003. PMID: 12538691

8

[Autoimmune liver disease: diagnosis and therapy].

Bayer EM, Schramm C, Kanzler S, Lohse AW. Bayer EM, et al. Among authors: schramm c. Z Gastroenterol. 2004 Jan;42(1):19-30. doi: 10.1055/s-2004-812686. Z Gastroenterol. 2004. PMID: 14997400 Review. German.

9

TGFbeta regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo.

Schramm C, Huber S, Protschka M, Czochra P, Burg J, Schmitt E, Lohse AW, Galle PR, Blessing M. Schramm C, et al. Int Immunol. 2004 Sep;16(9):1241-9. doi: 10.1093/intimm/dxh126. Epub 2004 Jul 12. Int Immunol. 2004. PMID: 15249539

10

Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells.

Huber S, Schramm C, Lehr HA, Mann A, Schmitt S, Becker C, Protschka M, Galle PR, Neurath MF, Blessing M. Huber S, et al. Among authors: schramm c. J Immunol. 2004 Dec 1;173(11):6526-31. doi: 10.4049/jimmunol.173.11.6526. J Immunol. 2004. PMID: 15557141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

616 results

Search Page